MFAP2 and central nervous system cancer: Contrastive research of 1,157 cases of normal tissues and 689 cases of glioma tissues in the TCGA-GTEx database showed that MFAP2 expression levels were significantly higher in glioma than in normal tissues (p < 0.001, Figure 1A).